The Global Fund has recently announced that its priorities for multi-country investments over the 2017-2019 funding cycle do not include HIV programs in Africa. This decision will affect eight current grants worth nearly $60 million, many of which have had less than two years of implementation
A two-drug, long-acting injectable regimen of HIV medications has demonstrated efficacy in maintaining HIV-1 viral suppression throughout almost two years of treatment. The results come from the ongoing LATTE-2 trial and were presented today at the 9th International AIDS Society (IAS) Conference on HIV Science, in Paris.Visit Page
Tablets made from dried leaves of the Artemisia annua plant cured 18 critically ill patients in a Congo clinic.
The results suggest a new and inexpensive treatment option for the mosquito-borne disease that affects 212 million people worldwide.Visit Page